PRS 101 FOUNDATIONS OF PHARMACY REGULATION PRS 101.3: THE DRUG ENFORCEMENT ADMINISTRATION REGULATORY ROLE DR. BRUSHWOOD S MONOGRAPH

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "PRS 101 FOUNDATIONS OF PHARMACY REGULATION PRS 101.3: THE DRUG ENFORCEMENT ADMINISTRATION REGULATORY ROLE DR. BRUSHWOOD S MONOGRAPH"

Transcription

1 PRS 101 FOUNDATIONS OF PHARMACY REGULATION PRS 101.3: THE DRUG ENFORCEMENT ADMINISTRATION REGULATORY ROLE DR. BRUSHWOOD S MONOGRAPH

2 PRS THE DRUG ENFORCEMENT ADMINISTRATION REGULATORY ROLE ACTIVITY DESCRIPTION This class explores how a law enforcement agency with a traditional supply-side focus on the interdiction and elimination of illicit drugs with no medical value, can expand its role into reducing abuse of prescription drugs that do have a legitimate role in medicine. The success of the War on Drugs is considered, along with the consequences of the warfare strategy toward drug abuse. The class compares the regulatory approaches of voluntary compliance and strong enforcement. The class reviews the regulatory implications for pharmacists of state assisted suicide and medical marijuana laws. This monograph can be taken as a standalone 1 credit hour home study in law (ACPE accredited) but is also a component of the Pharmacy Regulatory Specialist curriculum. To qualify as a PRS, one must enroll in each of the five (5) live PRS pharmacy law webinars given throughout the year and successfully complete twenty-six (26) one-credit monographs. Once all requirements have been completed, the participant must pass a final comprehensive exam (70% or higher) and pay $199 for the recording and issuing of the Pharmacy Regulatory Specialist Certificate. TARGET AUDIENCE The target audience for this activity is pharmacists and pharmacy technicians in hospital, community, and retail pharmacy settings. LEARNING OBJECTIVES After completing this activity, the pharmacist will be able to: Describe the authority of the DEA under the CSA Discuss the crisis of prescription drug abuse List major requirements for pharmacies under DEA regulations. ACCREDITATION PHARMACY PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. NURSING PharmCon, Inc. is approved by the California Board of Registered Nursing (Provider Number CEP 13649) and the Florida Board of Nursing (Provider Number ). Activities approved by the CA BRN and the FL BN are accepted by most State Boards of Nursing. CE hours provided by PharmCon, Inc. meet the ANCC criteria for formally approved continuing education hours. The ACPE is listed by the AANP as an acceptable, accredited continuing education organization for applicants seeking renewal through continuing education credit. For additional information, please visit Universal Activity No.: H03-P&T Credits: 1 contact hour (0.1 CEU) Release Date: April 1, 2014 Expiration Date: April 1, 2016 ACTIVITY TYPE Knowledge-Based Home Study Monograph FINANCIAL SUPPORT BY PharmCon After completing this activity, the pharmacy technician will be able to: Describe the authority of the DEA under the CSA Discuss the crisis of prescription drug abuse List major requirements for pharmacies under DEA regulations 1

3 ABOUT THE AUTHOR David Brushwood is professor of Pharmaceutical Outcomes and Policy at the University of Florida College of Pharmacy. A graduate of the schools of pharmacy and law at the University of Kansas, professor Brushwood practiced both professions prior to entering academia. Professor Brushwood has developed error prevention programs for several pharmacy chains. His research interests are in the areas of regulating for outcomes, medication error prevention, and pain management policy. He has received grant funding from numerous agencies including the Robert Wood Johnson Foundation, the National Institutes of Health, and the National Community Pharmacy Foundation. Professor Brushwood received the 2012 Pellegrino Medal. The award honors nationally-recognized leaders for contributions to healthcare ethics in the selfless spirit of Edmund D. Pellegrino. He also has twice been selected as a Mayday Scholar in Pain Policy by the American Society of Law, Medicine & Ethics. Professor Brushwood is a frequent contributor to pharmacy journals and to law journals. He developed, and serves as an advisor for the UF online Master of Science in Pharmacy, a graduate program offering seven areas of specialization in regulatory pharmaceutical fields. David Brushwood, JD, RPh Professor, University of Florida School of Pharmacy FACULTY DISCLOSURE It is the policy of PharmCon, Inc. to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) and/or service(s) discussed in an educational activity. David Brushwood reports no actual or potential conflict of interest in relation to this activity. Peer review of the material in this CE activity was conducted to assess and resolve potential conflict of interest. Reviewers unanimously found that the activity is fair balanced and lacks commercial bias. Please Note: PharmCon, Inc. does not view the existence of relationships as an implication of bias or that the value of the material is decreased. The content of the activity was planned to be balanced and objective. Occasionally, authors may express opinions that represent their own viewpoint. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient or pharmacy management. Conclusions drawn by participants should be derived from objective analysis of scientific data presented from this monograph and other unrelated sources. 2

4 3

5 4

6 5

7 6

8 7

9 8

10 9

11 10

12 ACTIVITY TEST 1. In what year did US Congress pass the Harrison Narcotics Tax Act? A B C D According to the Federation of State Medical Boards (FSMB), there is a state of biologic adaptation evidenced by a withdrawal syndrome when the drug is abruptly discontinued. What is this called according to FSMB definitions? A. Abuse. B. Tolerance. C. Dependence. D. Addiction. 3. According to the Supreme Court of the United States, what is the status of state-approved medical marijuana under federal law? A. Legal, because states have the right to determine what constitutes appropriate medical use. B. Legal, because the DEA approves of medical marijuana. C. Illegal, because consuming one s locally grown marijuana affects interstate commerce in marijuana. D. Illegal, because users of marijuana are hardened criminals who threaten society. 4. According to the Supreme Court of the United States, what is the status of state-approved assisted death under federal law? A. Legal, because states have the right to determine what constitutes appropriate medical use. B. Legal, because the CSA specifically approves assisted death as a legitimate medical purpose. C. Illegal, because assisted death in one state affects the dying process in all states. D. Illegal, because assisting death is immoral and it threatens society. 5. In what year was OxyContin approved? A B C D

13 6. What is the best solution to the problem of prescription drug abuse? A. Abuse-deterrent technology that uses an opioid antagonist. B. Abuse-deterrent technology that creates a gummy matrix when a tablet is crushed. C. Abuse-deterrent technology that includes a low dose of an aversive drug. D. A new molecule that is not abused. 7. If a wholesaler discovers a suspicious order from a pharmacy, to whom must this suspicious order be reported? A. The pharmacy s pharmacist in charge. B. The local police. C. The state board of pharmacy. D. The DEA. 8. With what frequency must a pharmacy DEA registration be renewed? A. Every year. B. Every two years. C. Every three years. D. Every four years. 9. If a pharmacy experiences a theft or significant loss of controlled substances, on what form must this be reported to the DEA? A. Form 41. B. Form 106. C. Form 222. D. Form 222a. 10. In a LTCF that has an automated dispensing system (ADS), drugs still contained within the system are considered whose property? A. They are considered LTCF property. B. They are considered pharmacy stock. C. They are considered the patient s property. D. They are considered the prescriber s property. Please submit your final responses on freece.com. Thank you. 12

OVERVIEW OF RECENT PHARMACY LAW CASES DAVID BRUSHWOOD, JD, RPH

OVERVIEW OF RECENT PHARMACY LAW CASES DAVID BRUSHWOOD, JD, RPH OVERVIEW OF RECENT PHARMACY LAW CASES DAVID BRUSHWOOD, JD, RPH OVERVIEW OR RECENT PHARMACY LAW CASES ACTIVITY DESCRIPTION This class reviews six legal cases in which allegations were made that pharmacy

More information

PRS 103 CONTEMPORARY ISSUES IN PHARMACY REGULATION PRS 103.6: LICENSURE AS ASSURANCE OF COMPETENCE DR. BRUSHWOOD S MONOGRAPH

PRS 103 CONTEMPORARY ISSUES IN PHARMACY REGULATION PRS 103.6: LICENSURE AS ASSURANCE OF COMPETENCE DR. BRUSHWOOD S MONOGRAPH PRS 103 CONTEMPORARY ISSUES IN PHARMACY REGULATION PRS 103.6: LICENSURE AS ASSURANCE OF COMPETENCE DR. BRUSHWOOD S MONOGRAPH PRS 103.6: LICENSURE AS ASSURANCE OF COMPETENCE ACTIVITY DESCRIPTION This monograph

More information

PRS 105 REGULATORY COMPLIANCE CASE STUDIES PRS 105.7: THE WHISTLEBLOWER DR. BRUSHWOOD S MONOGRAPH

PRS 105 REGULATORY COMPLIANCE CASE STUDIES PRS 105.7: THE WHISTLEBLOWER DR. BRUSHWOOD S MONOGRAPH PRS 105 REGULATORY COMPLIANCE CASE STUDIES PRS 105.7: THE WHISTLEBLOWER DR. BRUSHWOOD S MONOGRAPH PRS 105.7 THE WHISTLEBLOWER ACTIVITY DESCRIPTION This monograph presents the case study of United States

More information

NATURAL MEDICINES TO MANAGE DIABETES

NATURAL MEDICINES TO MANAGE DIABETES NATURAL MEDICINES TO MANAGE DIABETES ACTIVITY DESCRIPTION Some surveys have shown that more than 60 percent of people with diabetes use some type of supplement. There are many supplements which are traditionally

More information

A REVIEW OF FEDERAL PHARMACY LAW DONALD SULLIVAN, PH.D

A REVIEW OF FEDERAL PHARMACY LAW DONALD SULLIVAN, PH.D A REVIEW OF FEDERAL PHARMACY LAW DONALD SULLIVAN, PH.D A REVIEW OF FEDERAL PHARMACY LAW ACTIVITY DESCRIPTION This program will discuss the federal legal requirements for dispensing controlled substances

More information

PREVENTING MEDICATION ERRORS IN PHARMACY PRACTICE DR. SULLIVAN S SUPPLEMENTAL HANDOUT

PREVENTING MEDICATION ERRORS IN PHARMACY PRACTICE DR. SULLIVAN S SUPPLEMENTAL HANDOUT PREVENTING MEDICATION ERRORS IN PHARMACY PRACTICE DR. SULLIVAN S SUPPLEMENTAL HANDOUT PREVENTING MEDICATION ERRORS IN PHARMACY PRACTICE ACTIVITY DESCRIPTION Medications errors may occur more often than

More information

OH MY ACHING BODY: TACKLING FIBROMYALGIA GENEVA BRIGGS, PHARMD, BCPS

OH MY ACHING BODY: TACKLING FIBROMYALGIA GENEVA BRIGGS, PHARMD, BCPS OH MY ACHING BODY: TACKLING FIBROMYALGIA GENEVA BRIGGS, PHARMD, BCPS OH MY ACHING BODY: TACKLING FIBROMYALGIA ACTIVITY DESCRIPTION Fibromyalgia dramatically impacts the lives of those affected. This program

More information

BE WISE, IMMUNIZE: AN UPDATE ON IMMUNIZATION PRACTICES GRETCHEN KRECKEL GAROFOLI, PHARMD

BE WISE, IMMUNIZE: AN UPDATE ON IMMUNIZATION PRACTICES GRETCHEN KRECKEL GAROFOLI, PHARMD BE WISE, IMMUNIZE: AN UPDATE ON IMMUNIZATION PRACTICES GRETCHEN KRECKEL GAROFOLI, PHARMD BE WISE, IMMUNIZE: AN UPDATE ON IMMUNIZATION PRACTICES ACTIVITY DESCRIPTION With over 230,000 pharmacists trained

More information

DEFENDING A FEDERAL CRIMINAL CHARGE AND A BOARD ACTION ROBERT ESGRO, RPH, ESQ

DEFENDING A FEDERAL CRIMINAL CHARGE AND A BOARD ACTION ROBERT ESGRO, RPH, ESQ DEFENDING A FEDERAL CRIMINAL CHARGE AND A BOARD ACTION ROBERT ESGRO, RPH, ESQ DEFENDING A FEDERAL CRIMINAL CHARGE AND A BOARD ACTION ACTIVITY DESCRIPTION Generally, medical malpractice is litigated as

More information

PICKING UP THE PIECES: TREATING POST-ACUTE SEQUELAE OF TRAUMATIC BRAIN INJURY ASHLEY KHAN, PHARMD

PICKING UP THE PIECES: TREATING POST-ACUTE SEQUELAE OF TRAUMATIC BRAIN INJURY ASHLEY KHAN, PHARMD PICKING UP THE PIECES: TREATING POST-ACUTE SEQUELAE OF TRAUMATIC BRAIN INJURY ASHLEY KHAN, PHARMD PICKING UP THE PIECES: TREATING POST-ACUTE SEQUELAE OF TRAUMATIC BRAIN INJURY ACTIVITY DESCRIPTION Close

More information

NEW AND EMERGING THERAPIES IN THE TREATMENT OF SEASONAL ALLERGIES

NEW AND EMERGING THERAPIES IN THE TREATMENT OF SEASONAL ALLERGIES NEW AND EMERGING THERAPIES IN THE TREATMENT OF SEASONAL ALLERGIES ACTIVITY DESCRIPTION Each year millions of people suffer from the symptoms of allergic rhinitis, which includes annoying running nose,

More information

REVIEW OF FEDERAL LAW FOR PHARMACY TECHNICIANS DR. SULLIVAN S MONOGRAPH

REVIEW OF FEDERAL LAW FOR PHARMACY TECHNICIANS DR. SULLIVAN S MONOGRAPH REVIEW OF FEDERAL LAW FOR PHARMACY TECHNICIANS DR. SULLIVAN S MONOGRAPH REVIEW OF FEDERAL LAW FOR PHARMACY TECHNICIANS ACTIVITY DESCRIPTION This program will assist pharmacy technicians to understand the

More information

WHEN THE STARS ALIGN AND YOUR PATIENT IS IN SYNC: ADHERENCE RISES MARK GAROFOLI, PHARMD, MBA, CGP PETE KRECKEL, RPH

WHEN THE STARS ALIGN AND YOUR PATIENT IS IN SYNC: ADHERENCE RISES MARK GAROFOLI, PHARMD, MBA, CGP PETE KRECKEL, RPH WHEN THE STARS ALIGN AND YOUR PATIENT IS IN SYNC: ADHERENCE RISES MARK GAROFOLI, PHARMD, MBA, CGP PETE KRECKEL, RPH WHEN THE STARS ALIGN AND YOUR PATIENT IS IN SYNC: ADHERENCE RISES ACTIVITY DESCRIPTION

More information

RHEUMATOID ARTHRITIS: PRIMARILY AN AUTOIMMUNE DISEASE JOHNATHON DUFTON, MD

RHEUMATOID ARTHRITIS: PRIMARILY AN AUTOIMMUNE DISEASE JOHNATHON DUFTON, MD RHEUMATOID ARTHRITIS: PRIMARILY AN AUTOIMMUNE DISEASE JOHNATHON DUFTON, MD RHEUMATOID ARTHRITIS: PRIMARILY AN AUTOIMMUNE DISEASE ACTIVITY DESCRIPTION Rheumatoid arthritis (RA) is an inflammatory type of

More information

MOVEMENT BEYOND LAXATIVES: EVOLVING PHARMACOLOGIC OPTIONS FOR IBS-C AND CIC PETE KRECKEL, RPH

MOVEMENT BEYOND LAXATIVES: EVOLVING PHARMACOLOGIC OPTIONS FOR IBS-C AND CIC PETE KRECKEL, RPH MOVEMENT BEYOND LAXATIVES: EVOLVING PHARMACOLOGIC OPTIONS FOR IBS-C AND CIC PETE KRECKEL, RPH MOVEMENT BEYOND LAXATIVES: EVOLVING PHARMACOLOGIC OPTIONS FOR IBS-C AND CIC ACTIVITY DESCRIPTION IBS-C and

More information

ON PENS AND NEEDLES A PRIMER ON INSULIN PENS AND PROPER INJECTION TECHNIQUES PETE KRECKEL, RPH

ON PENS AND NEEDLES A PRIMER ON INSULIN PENS AND PROPER INJECTION TECHNIQUES PETE KRECKEL, RPH ON PENS AND NEEDLES A PRIMER ON INSULIN PENS AND PROPER INJECTION TECHNIQUES PETE KRECKEL, RPH ON PENS AND NEEDLES - A PRIMER ON INSULIN PENS AND PROPER INJECTION TECHNIQUES ACTIVITY DESCRIPTION Insulin

More information

NEW UPDATES IN OTC PRODUCTS: 2014 DONALD SULLIVAN, PHARMD

NEW UPDATES IN OTC PRODUCTS: 2014 DONALD SULLIVAN, PHARMD NEW UPDATES IN OTC PRODUCTS: 2014 DONALD SULLIVAN, PHARMD NEW UPDATES IN OTC PRODUCTS: 2014 ACTIVITY DESCRIPTION The program will discuss recently marketed OTC products including their place in therapy,

More information

CAN SUPPLEMENTS BE USED TO MANAGE ATTENTION DEFICIT/HYPERACTIVITY DISORDER? GENEVA BRIGGS, PHARMD, BCPS

CAN SUPPLEMENTS BE USED TO MANAGE ATTENTION DEFICIT/HYPERACTIVITY DISORDER? GENEVA BRIGGS, PHARMD, BCPS CAN SUPPLEMENTS BE USED TO MANAGE ATTENTION DEFICIT/HYPERACTIVITY DISORDER? GENEVA BRIGGS, PHARMD, BCPS CAN SUPPLEMENTS BE USED TO MANAGE ATTENTION DEFICIT/HYPERACTIVITY DISORDER? ACTIVITY DESCRIPTION

More information

TESTOSTERONE REPLACEMENT THERAPY FOR THE AGING MALE: COUNSELING INSIGHTS FOR THE PHARMACIST TIM DRAKE, PHARM.D.

TESTOSTERONE REPLACEMENT THERAPY FOR THE AGING MALE: COUNSELING INSIGHTS FOR THE PHARMACIST TIM DRAKE, PHARM.D. TESTOSTERONE REPLACEMENT THERAPY FOR THE AGING MALE: COUNSELING INSIGHTS FOR THE PHARMACIST TIM DRAKE, PHARM.D. TESTOSTERONE REPLACEMENT THERAPY FOR THE AGING MALE: COUNSELING INSIGHTS FOR THE PHARMACIST

More information

ALOPECIA AREATA: SPOT BALDNESS & HAIR LOSS DR. DUFTON S SUPPLEMENTAL HANDOUT

ALOPECIA AREATA: SPOT BALDNESS & HAIR LOSS DR. DUFTON S SUPPLEMENTAL HANDOUT ALOPECIA AREATA: SPOT BALDNESS & HAIR LOSS DR. DUFTON S SUPPLEMENTAL HANDOUT ALOPECIA AREATA: SPOT BALDNESS & HAIR LOSS ACTIVITY DESCRIPTION Alopecia areata is a relatively mysterious condition in which

More information

SHOULD WE ALL TAKE OMEGA-3 FATTY ACID SUPPLEMENTS? GENEVA BRIGGS, PHARMD, BCPS

SHOULD WE ALL TAKE OMEGA-3 FATTY ACID SUPPLEMENTS? GENEVA BRIGGS, PHARMD, BCPS SHOULD WE ALL TAKE OMEGA-3 FATTY ACID SUPPLEMENTS? GENEVA BRIGGS, PHARMD, BCPS SHOULD WE ALL TAKE OMEGA-3 FATTY ACID SUPPLEMENTS? ACTIVITY DESCRIPTION The benefits of increasing intake of omega-3 fatty

More information

ANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS LAUREN HYNICKA, PHARM.D.

ANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS LAUREN HYNICKA, PHARM.D. ANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS LAUREN HYNICKA, PHARM.D. ANTIBIOTICS FROM HEAD TO TOE: PART 5 - URINARY TRACT INFECTIONS ACTIVITY DESCRIPTION Antibiotic use in the safest

More information

ALL IN THE FAMILY 75 YEARS OF DIABETES TREATMENT OPTIONS FROM GLASS SYRINGES TO SGLT2 INHIBITORS PETER A. KRECKEL, R.PH.

ALL IN THE FAMILY 75 YEARS OF DIABETES TREATMENT OPTIONS FROM GLASS SYRINGES TO SGLT2 INHIBITORS PETER A. KRECKEL, R.PH. ALL IN THE FAMILY 75 YEARS OF DIABETES TREATMENT OPTIONS FROM GLASS SYRINGES TO SGLT2 INHIBITORS PETER A. KRECKEL, R.PH. ALL IN THE FAMILY 75 YEARS OF DIABETES TREATMENT OPTIONS FROM GLASS SYRINGES TO

More information

Prescription and Next-Generation Omega-3 Fatty Acids

Prescription and Next-Generation Omega-3 Fatty Acids Prescription and Next-Generation Omega-3 Fatty Acids Event Type Live Online Expiration Date 2/10/2017 Credits 1 Contact Hour Target Audience Nurses, Pharmacists, Pharmacy Technicians Program Overview Recommendations

More information

MEMBER S CHOICE: THE REQUESTED SPANISH PHRASES FOR THE PHARMACY STEPHANIE LANGSTON, MFLE

MEMBER S CHOICE: THE REQUESTED SPANISH PHRASES FOR THE PHARMACY STEPHANIE LANGSTON, MFLE MEMBER S CHOICE: THE REQUESTED SPANISH PHRASES FOR THE PHARMACY STEPHANIE LANGSTON, MFLE MEMBER S CHOICE: THE REQUESTED SPANISH PHRASES FOR THE ACTIVITY DESCRIPTION Verification of identity, drug allergies

More information

SUGAR IN THE CITY: CHALLENGES OF INNER CITY HEALTH DISPARITIES IN THE MANAGEMENT OF DIABETES MARY LYNN MCPHERSON, PHARMD, BCPS, CDE

SUGAR IN THE CITY: CHALLENGES OF INNER CITY HEALTH DISPARITIES IN THE MANAGEMENT OF DIABETES MARY LYNN MCPHERSON, PHARMD, BCPS, CDE SUGAR IN THE CITY: CHALLENGES OF INNER CITY HEALTH DISPARITIES IN THE MANAGEMENT OF DIABETES MARY LYNN MCPHERSON, PHARMD, BCPS, CDE SUGAR IN THE CITY: CHALLENGES OF INNER CITY HEALTH DISPARITIES IN THE

More information

UNDERSTANDING AND TREATING ADHD TAMMIE LEE DEMLER, PHARMD, MBA, BCPP

UNDERSTANDING AND TREATING ADHD TAMMIE LEE DEMLER, PHARMD, MBA, BCPP UNDERSTANDING AND TREATING ADHD TAMMIE LEE DEMLER, PHARMD, MBA, BCPP UNDERSTANDING AND TREATING ADHD ACTIVITY DESCRIPTION Pharmacists can play a pro-active role in the treatment of ADHD. Management of

More information

A FOCUS ON TOPICS IN OHIO PHARMACY LAW -- OHIO STATE BOARD OF PHARMACY APPROVED DR. SULLIVAN S MONOGRAPH

A FOCUS ON TOPICS IN OHIO PHARMACY LAW -- OHIO STATE BOARD OF PHARMACY APPROVED DR. SULLIVAN S MONOGRAPH A FOCUS ON TOPICS IN OHIO PHARMACY LAW -- OHIO STATE BOARD OF PHARMACY APPROVED DR. SULLIVAN S MONOGRAPH A FOCUS ON TOPICS IN OHIO PHARMACY LAW -- OHIO STATE BOARD OF PHARMACY APPROVED ACTIVITY DESCRIPTION

More information

Compounded Medicines: New Laws, New Responsibilities, New Questions

Compounded Medicines: New Laws, New Responsibilities, New Questions Compounded Medicines: New Laws, New Responsibilities, New Questions ACTIVITY DESCRIPTION The implementation of the Drug Quality and Security Act, enacted by Congress in 2013, has created conflicts between

More information

Controlled Substance Prescribing Laws, The Prescription Monitoring Program, and Preventing Drug Diversion

Controlled Substance Prescribing Laws, The Prescription Monitoring Program, and Preventing Drug Diversion Controlled Substance Prescribing Laws, The Prescription Monitoring Program, and Preventing Drug Diversion Michael Halse, PharmD PGY1 Resident Pharmacist South County Hospital and Healthcare System Disclosures

More information

MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS

MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS David Gaugh, R.Ph. Senior Vice President for Sciences and Regulatory

More information

Exceptions to the Rule: A Pharmacy Law Presentation. Objectives DISCLAIMER 10/16/2015

Exceptions to the Rule: A Pharmacy Law Presentation. Objectives DISCLAIMER 10/16/2015 Exceptions to the Rule: A Pharmacy Law Presentation Eric Roath, Pharm.D. Director of Professional Practice Michigan Pharmacists Association Objectives 1. Identify basic legal frameworks that govern the

More information

The Administration s Response to the Prescription Drug Epidemic: Action Items

The Administration s Response to the Prescription Drug Epidemic: Action Items The Administration s Response to the Prescription Drug Epidemic: Action Items As outlined in Epidemic: Responding to America s Prescription Drug Abuse Crisis, below are the action items identified in the

More information

What Every Practitioner Needs to Know About Controlled Substance Prescribing

What Every Practitioner Needs to Know About Controlled Substance Prescribing What Every Practitioner Needs to Know About Controlled Substance Prescribing New York State Department of Health Use of Controlled Substances Controlled substances can be effective in the treatment of

More information

Substance Use: Addressing Addiction and Emerging Issues

Substance Use: Addressing Addiction and Emerging Issues MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population

More information

PHARMACY TECHNICIAN LICENSURE S.B. 92: ANALYSIS AS ENACTED

PHARMACY TECHNICIAN LICENSURE S.B. 92: ANALYSIS AS ENACTED PHARMACY TECHNICIAN LICENSURE S.B. 92: ANALYSIS AS ENACTED Senate Bill 92 (as enacted) PUBLIC ACT 285 of 2014 Sponsor: Senator Mike Green Senate Committee: Regulatory Reform House Committee: Health Policy

More information

ANALYSIS AS REPORTED FROM COMMITTEE

ANALYSIS AS REPORTED FROM COMMITTEE PHARMACY TECHNICIAN LICENSURE S.B. 92 (S-5): ANALYSIS AS REPORTED FROM COMMITTEE Senate Bill 92 (Substitute S-5 as reported by the Committee of the Whole) (as passed by the Senate) Sponsor: Senator Mike

More information

2014, That Was The Year That Was Greg Baran, RPh, MA, FMPA Baran Consulting LLC

2014, That Was The Year That Was Greg Baran, RPh, MA, FMPA Baran Consulting LLC 2014, That Was The Year That Was Greg Baran, RPh, MA, FMPA Baran Consulting LLC Objectives 1. Review the changes to the pharmacy practice act related to sterile compounding. 2. Understand the role of the

More information

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District Massachusetts Substance Abuse Policy and Practices Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District November 2014 Substance Abuse and Addiction National and State opioid abuse

More information

Opioid Prescribing Practices and Pain Management: Role of FDA Douglas C. Throckmorton, MD Deputy Director for Regulator Programs, CDER, FDA

Opioid Prescribing Practices and Pain Management: Role of FDA Douglas C. Throckmorton, MD Deputy Director for Regulator Programs, CDER, FDA Opioid Prescribing Practices and Pain Management: Role of FDA Douglas C. Throckmorton, MD Deputy Director for Regulator Programs, CDER, FDA American Academy of Hospice and Palliative Care Medicine October,

More information

Overview of Recent Pharmacy Law Cases

Overview of Recent Pharmacy Law Cases Overview of Recent Pharmacy Law Cases ACTIVITY DESCRIPTION This class reviews six legal cases in which allegations were made that pharmacy personnel had failed to meet their legal responsibilities. The

More information

Privacy Space. Public Place. How to Protect PHI and be HIPAA Compliant

Privacy Space. Public Place. How to Protect PHI and be HIPAA Compliant Privacy Space. Public Place. How to Protect PHI and be HIPAA Compliant Event Type Live Online ACPE Expiration Date 12/11/2016 Credits 1 Contact Hour Target Audience Pharmacy Technicians Program Overview

More information

Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998

Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998 Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998 Section I: Preamble The New Hampshire Medical Society believes that principles

More information

Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy

Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy Colorado Prescription Drug Monitoring Program Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy DORA is dedicated to preserving the integrity of the marketplace

More information

Office-Based Treatment of Opioid Dependence

Office-Based Treatment of Opioid Dependence Office-Based Treatment of Opioid Dependence Saturday, November 5, 2011 12:30 PM to 5:30 PM Mason General Hospital, Shelton, Washington PROGRAM OVERVIEW Washington State is currently facing an epidemic

More information

For a Healthier America: Reducing Prescription Drug Misuse and Abuse

For a Healthier America: Reducing Prescription Drug Misuse and Abuse For a Healthier America: Reducing Prescription Drug Misuse and Abuse The misuse and abuse of prescription medicines is a growing public health problem. In addition to the tragic toll on families and communities,

More information

State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations

State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations There is currently an epidemic of prescription opioid abuse, misuse and diversion in the U.S. Numerous federal,

More information

STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council

STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council PRIORITY AREA: PRESCRIBERS Recommendation: The Council recommends that

More information

247 CMR: BOARD OF REGISTRATION IN PHARMACY

247 CMR: BOARD OF REGISTRATION IN PHARMACY 247 CMR 2.00: DEFINITIONS Section 2.00: Definitions 2.00: Definitions Additional definitions pertaining to: (1) nuclear pharmacies are contained in 247 CMR 13.00: Registration Requirements and Minimal

More information

2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov

2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM 2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM What is OARRS? To address the growing misuse and diversion

More information

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS. These regulations are promulgated as authorized by the Act.

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS. These regulations are promulgated as authorized by the Act. CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS Section 1. Authority. These regulations are promulgated as authorized by the Act. Section 2. Definitions. Direct supervision means that a licensed pharmacist

More information

CURES Prescription Drug Monitoring Program

CURES Prescription Drug Monitoring Program California Department of Justice CURES Prescription Drug Monitoring Program February, 2013 The mission of the California Prescription Drug Monitoring Program (PDMP) is to eliminate pharmaceutical drug

More information

DEA Washington Division Diversion Control Program

DEA Washington Division Diversion Control Program SOUTHWEST VIRGINIA PRESCRIPTION DRUG ABUSE SUMMIT DEA Washington Division Diversion Control Program Mary Johnson-Rochee Diversion Program Manager November 14, 2012 Topics: DEA s Diversion Mission How DEA

More information

Information for Pharmacists

Information for Pharmacists Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl

More information

Treating Pain: New Guidelines for Using Controlled Substances. Jason F. Arnold, JD, MPH Associate Director, Institute of Human Values in Health Care

Treating Pain: New Guidelines for Using Controlled Substances. Jason F. Arnold, JD, MPH Associate Director, Institute of Human Values in Health Care Please cite: Arnold J, Sade RMS/slk. Treating Pain: New Guidelines for Using controlled Substances. Journal South Carolina Medical Association 2000;96(3):105-10 Treating Pain: New Guidelines for Using

More information

Increasing Access to Opioid Addiction Treatment

Increasing Access to Opioid Addiction Treatment Report to The Vermont Legislature Increasing Access to Opioid Addiction Treatment In Accordance with Act 75, 2013, Section 14b An Act Relating to Strengthening Vermont s Response to Opioid Addiction and

More information

2015 Annual Convention

2015 Annual Convention 2015 Annual Convention Date: Saturday, October 10, 2015 Time: 11:45 am 12:15 pm Location: Gaylord National Harbor Resort and Convention Center, Chesapeake 7/8/9 Title: Activity Type: Speaker: Update on

More information

"Electronic Prescribing of Controlled Substances: Addressing Health Care and Law Enforcement Priorities" Before the Senate Judiciary Committee

Electronic Prescribing of Controlled Substances: Addressing Health Care and Law Enforcement Priorities Before the Senate Judiciary Committee DEA Congressional Testimony December 4, 2007 Statement of Joseph T. Rannazzisi Deputy Assistant Administrator Office of Diversion Control Drug Enforcement Administration "Electronic Prescribing of Controlled

More information

U.S. Bureau of Labor Statistics. Pharmacy Tech

U.S. Bureau of Labor Statistics. Pharmacy Tech From the: U.S. Bureau of Labor Statistics Pharmacy Tech Pharmacy technicians fill prescriptions and check inventory. Pharmacy technicians help licensed pharmacists dispense prescription medication. They

More information

Prescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth

Prescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth Prescription drug abuse trends Minnesota s Prescription Monitoring Program Carol Falkowski Drug Abuse Dialogues www.drugabusedialogues.com Barbara Carter, Manager MN Board of Pharmacy www.pmp.pharmacy.state.mn.us

More information

PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA

PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA Research current through July 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.

More information

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS. These regulations are promulgated as authorized by the Act.

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS. These regulations are promulgated as authorized by the Act. CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS Section 1. Authority. These regulations are promulgated as authorized by the Act. Section 2. Definitions. (a) "Pharmacy Technician-in-training" means an individual

More information

Prescription Drug Monitoring Program Administrators Guide for Training Law Enforcement

Prescription Drug Monitoring Program Administrators Guide for Training Law Enforcement Prescription Drug Monitoring Program Administrators Guide for Training Law Enforcement 2013 Telephone: (781) 609-7741 Fax: (888) 705-8053 Email: info@pdmpassist.org Website: www.pdmpassist.org INTRODUCTION

More information

What you should know about treating your pain with opioids. Important information on the safe use of opioid pain medicine.

What you should know about treating your pain with opioids. Important information on the safe use of opioid pain medicine. What you should know about treating your pain with opioids Important information on the safe use of opioid pain medicine. If your healthcare provider has determined that opioid therapy is right for you,

More information

Pharmacy Technician Overview The Field - Preparation - Day in the Life - Earnings - Employment - Career Path Forecast - Professional Organizations

Pharmacy Technician Overview The Field - Preparation - Day in the Life - Earnings - Employment - Career Path Forecast - Professional Organizations Pharmacy Technician Overview The Field - Preparation - Day in the Life - Earnings - Employment - Career Path Forecast - Professional Organizations The Field Pharmacy technicians help licensed pharmacists

More information

Prescription Drug Monitoring Program. A Powerful Tool

Prescription Drug Monitoring Program. A Powerful Tool Prescription Drug Monitoring Program A Powerful Tool September 16, 2015 No reportable financial interest. Controlled Substance Utilization Review and Evaluation System >16,000 Prescription Painkiller Overdose

More information

REGULATION 3 PHARMACY TECHNICIANS

REGULATION 3 PHARMACY TECHNICIANS REGULATION 3 PHARMACY TECHNICIANS 03-00 PHARMACY TECHNICIANS REGISTRATION/PERMIT REQUIRED 03-00-0001 DEFINITIONS (a) Pharmacy technician means those individuals, exclusive of pharmacy interns, who assist

More information

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS TABLE OF CONTENTS

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS TABLE OF CONTENTS CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS TABLE OF CONTENTS Section 1. Authority.... 1 Section 2. Definitions.... 1 Section 3. Qualifications and Requirements for Pharmacy Technicians and Pharmacy Technicians-in-Training....

More information

HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR

HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR HOUSE OF REPRESENTATIVES STAFF ANALYSIS BILL #: HB 371 CS Cancer Drug Donation Program SPONSOR(S): Harrell TIED BILLS: IDEN./SIM. BILLS: SB 1310 REFERENCE ACTION ANALYST STAFF DIRECTOR 1) Health Care General

More information

5 year analysis of Pharmacy Burglary and Robbery Experience

5 year analysis of Pharmacy Burglary and Robbery Experience PHARMACY CRIME Page 1 of 13 5 year analysis of Pharmacy Burglary and Robbery Experience Data used in this report is derived primarily from I-Partners claims information and Pharmacists Mutual s proprietary

More information

Remote Automated Dispensing Machines in Long Term Care

Remote Automated Dispensing Machines in Long Term Care Remote Automated Dispensing Machines in Long Term Care This technology is supported by DEA, CMS, EPA, and many state boards of pharmacy. See below for the NABP model rules, DEA Title 21 Sec. 1301.27 pertaining

More information

The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section

The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section TITLE I: PREVENTION SUBTITLE A- PRESCRIBER EDUCATION PRACTITIONER EDUCATION This subtitle requires practitioners who

More information

Methadone. Buprenorphine 10/9/2015

Methadone. Buprenorphine 10/9/2015 Medication Assisted Treatment for Opioid Addiction Tanya Hiser, MS, LPC Premier Care of Wisconsin, LLC October 21, 2015 How Did We Get Here? Civil War veterans and women 19th Century physicians cautious

More information

Pharmacy Jurisprudence, LLC

Pharmacy Jurisprudence, LLC Pharmacy Jurisprudence, LLC For pharmacists in states with a pharmacy law continuing education (CE) requirement, we offer our CE booklet without government or commercial funding. Index: 2 Should I Fill

More information

MA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations

MA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations MA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations Pri-Med Institute Marissa Seligman, PharmD mseligman@pri-medinstitute.org DISCLAIMER: For informational

More information

Michigan Board of Nursing Guidelines for the Use of Controlled Substances for the Treatment of Pain

Michigan Board of Nursing Guidelines for the Use of Controlled Substances for the Treatment of Pain JENNIFER M. GRANHOLM GOVERNOR STATE OF MICHIGAN DEPARTMENT OF COMMUNITY HEALTH LANSING JANET OLSZEWSKI DIRECTOR Michigan Board of Nursing Guidelines for the Use of Controlled Substances for the Treatment

More information

NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS

NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS This project was supported by Grant No. G1299ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions in this

More information

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015 Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015 ABC-MAP Board Meeting Agenda Prescription Drug Monitoring Background ABC-MAP Overview Board Responsibilities

More information

Purpose... 2. What s new?... 2. Role of pharmacists and pharmacy technicians in physician-assisted death... 3

Purpose... 2. What s new?... 2. Role of pharmacists and pharmacy technicians in physician-assisted death... 3 Table of Contents Purpose... 2 What s new?... 2 Role of pharmacists and pharmacy technicians in physician-assisted death... 3 Complying with ACP s Standards of Practice for Pharmacists and Pharmacy Technicians...

More information

Delaware. Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency

Delaware. Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Delaware Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency Nettesheim, Samantha -

More information

MEDICAL ASSISTANCE BULLETIN

MEDICAL ASSISTANCE BULLETIN ISSUE DATE September 4, 2015 SUBJECT EFFECTIVE DATE September 9, 2015 MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments, Oral Buprenorphine Agents - Pharmacy

More information

Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain

Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain Section I: Preamble The Michigan Boards of Medicine and Osteopathic Medicine & Surgery recognize that principles of quality

More information

SCOPE of Pain: Safe and Competent Opioid Prescribing Education

SCOPE of Pain: Safe and Competent Opioid Prescribing Education SCOPE of Pain: Safe and Competent Opioid Prescribing Education Disclosure of Support Our program is funded by an independent educational grant awarded by the manufacturers of extended-release (ER) and

More information

WHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE

WHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE WHAT WE KNOW The misuse and abuse of prescription drugs has become a leading cause of harm among New Hampshire adults,

More information

Controlled Substances Prescription Monitoring Program. Dean Wright, RPh Arizona State Board of Pharmacy

Controlled Substances Prescription Monitoring Program. Dean Wright, RPh Arizona State Board of Pharmacy Controlled Substances Prescription Monitoring Program Dean Wright, RPh Arizona State Board of Pharmacy Controlled Substances Prescription Monitoring Program Arizona s Forty-eighth Legislature passed H.B.

More information

Treatment Programs (OMTP)

Treatment Programs (OMTP) Sponsored by: Continuing Medical Education Program best practices for Opiate Maintenance Treatment Programs (OMTP) Avoid Abuse, Limit Liability May 8-11, 2012 December 4-7, 2012 Case Western Reserve University

More information

Pharmacy Program Pre-Test

Pharmacy Program Pre-Test Last Name: Pharmacy Program Pre-Test * For each question, put a check mark for the one option that you think is correct. 1. A pharmacist receives a security prescription from a known local medical group

More information

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS. These regulations are promulgated as authorized by the Act.

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS. These regulations are promulgated as authorized by the Act. CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS Section 1. Authority. These regulations are promulgated as authorized by the Act. Section 2. Definitions. (a) "Pharmacy Technician-in-training" means an individual

More information

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION Effective June 13, 2010 02-313, 02-373, 02-380, 02-383, 02-396 Chapter 21 page 1 02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION 313 BOARD OF DENTAL EXAMINERS 373 BOARD OF LICENSURE IN MEDICINE

More information

2014 Legislative Session. Disclosure. Florida Pharmacy Laws(Statutes) Objectives. 465.014 (1) Pharmacy Technician. FL Pharmacy Law Update May 24, 2014

2014 Legislative Session. Disclosure. Florida Pharmacy Laws(Statutes) Objectives. 465.014 (1) Pharmacy Technician. FL Pharmacy Law Update May 24, 2014 2014 Legislative Session FL Pharmacy Law Update May 24, 2014 Norman Tomaka, MS, BS Pharm, FAPhA Board of Directors, FSHP HB 323/SB 278 HB 7077/SB 662 HB 859/SB 962 SB 7016 HQS1 Relating to Pharmacy Technicians

More information

Controlled substances Identifying risks and internal audit focus areas

Controlled substances Identifying risks and internal audit focus areas Controlled substances Identifying risks and internal audit focus areas Introduction With a mission focused on improving the health of patients and taking care of the sick, health care providers face unique

More information

11/26/2012. Implementation of Florida s PDMP. Disclosure

11/26/2012. Implementation of Florida s PDMP. Disclosure Implementation of Florida s PDMP Rebecca R. Poston Program Manager December 1, 2012 Disclosure I have no vested interest in or affiliation with any corporate organizations offering financial support or

More information

Pharmacy Law Overview. From Civil Liability to Criminal Prosecution

Pharmacy Law Overview. From Civil Liability to Criminal Prosecution Pharmacy Law Overview From Civil Liability to Criminal Prosecution Law That Matters To Pharmacists Robert P. Esgro, R.Ph., Esq. Pharmacy Lawyer and Consultant 610-308-6666 Bob@PharmacyLawyer.com Pharmacy

More information

MEDICAL ASSISTANCE BULLETIN

MEDICAL ASSISTANCE BULLETIN ISSUE DATE SUBJECT EFFECTIVE DATE MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments Pharmacy Service Leesa M. Allen, Deputy Secretary Office of Medical

More information

The New Pharmacology for Medical Careers

The New Pharmacology for Medical Careers The New Pharmacology for Medical Careers Ohio Connections to Education Conference July 28, 2015 Nick Milasnovich National Sales Manager What s New with On-Line Program? All sections (Except Calculations)

More information

Federal Regulations For Prescribing Scheduled Controlled Substances

Federal Regulations For Prescribing Scheduled Controlled Substances Federal Regulations For Prescribing Scheduled Controlled Substances HEIT TEMPLATE.PPT 1 Central Principle of Balance With the Use of Controlled Substances Dual imperative of government Establish a system

More information

The Prescription Drug Abuse and Heroin Crisis: New York s Response

The Prescription Drug Abuse and Heroin Crisis: New York s Response The Prescription Drug Abuse and Heroin Crisis: New York s Response Joshua S. Vinciguerra, Director Bureau of Narcotic Enforcement October 28, 2015 October 28, 2015 2 The Connection States with more opioid

More information

Published by Waterford Life Sciences, Washington, DC 202-299-0600 Cover and book design: Gretchen Maxwell, GLM Design

Published by Waterford Life Sciences, Washington, DC 202-299-0600 Cover and book design: Gretchen Maxwell, GLM Design Copyright 2007 Scott M. Fishman, MD CME Activity Copyright 2009 The University of Wisconsin Board of Regents Published by Waterford Life Sciences, Washington, DC 202-299-0600 Cover and book design: Gretchen

More information

Guidelines for the use of DEA Registration number by House Staff

Guidelines for the use of DEA Registration number by House Staff Guidelines for the use of DEA Registration number by House Staff This document seeks to provide answers to a number of questions that have arisen within New York University School of Medicine/NYU Hospitals

More information

SENATE... No. 2142. The Commonwealth of Massachusetts. In the Year Two Thousand Fourteen

SENATE... No. 2142. The Commonwealth of Massachusetts. In the Year Two Thousand Fourteen SENATE.............. No. 2142 Tuesday, May 13, 2014 Text of the Senate Bill to increase opportunities for long-term substance abuse recovery (being the text of Senate, No. 2133, printed as amended). The

More information